The largest database of trusted experimental protocols

Facsscan flow cytometer

Manufactured by BD
Sourced in United States, Germany

The FACSscan flow cytometer is a laboratory instrument used for the analysis of cells or other particles in a fluid suspension. It is designed to measure and analyze the physical and fluorescent characteristics of these particles as they pass through a laser beam. The FACSscan is capable of detecting and quantifying multiple parameters simultaneously, providing researchers with detailed information about the properties of the samples under investigation.

Automatically generated - may contain errors

71 protocols using facsscan flow cytometer

1

Cell Cycle Analysis of ZINC69391 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synchronized cell populations were treated with 50 μM of ZINC69391 or 0.05% (v/v) DMSO (vehicle) for 15h. After treatment, cells were harvested, washed with ice-cold PBS, fixed overnight by addition of 70% (v/v) ethanol and stored at -20°C for a minimum of 24h. On the day of flow cytometry analysis, cell suspensions were washed with ice-cold PBS and re-suspended in 50 μl RNase A (100 μg/ml) at room temperature for 15 min.
Propidium Iodide was added to a final concentration of 20 μg/ml and incubated in dark at room temperature for 20 min. Cell cycle phase distributions were analyzed by FACS Scan Flow Cytometer (Beckton-Dickinson CA, USA). Data from at least three independent experiments were analyzed using ModFit software (VeritySoftware House Inc., Topsham, ME, USA) to determine the fractions of cells in the subG0/G1, G0/G1, S and G2/M phases from cell cycle distribution.
+ Open protocol
+ Expand
2

Mitochondrial Membrane Potential Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ΔΨm was determined in phosphate based-buffer, pH 7.4. Washed platelets (1 mg protein/mL) were incubated at 37°C with 0.25 μM rhodamine 6G [19 ] or 2 μM 5,5´,6,6-tetrachloro-1,1´,3,3´-tetraethyl-benzimidazolyl-carbocyanine iodide (JC-1) [20 (link)]. For rhodamine, fluorescence was registered in a RF 5301PC spectrofluorophotometer (Shimadzu Scientific Instruments, Maryland, USA) using 480 nm and 565 nm for excitation and emission wavelengths, respectively. Maximal fluorescence indicating total ΔΨm was attained for each experiment after adding 2.5 μM CCCP. For JC-1 assays, washed platelets (1x104 platelets/μL) were analyzed in a FACS Scan flow cytometer (Beckton Dickinson, San Jose, CA) at 37°C, the excitation wavelength was 488 nm and the emission wavelengths were 535 nm for green (FL1) and 590 nm for red (FL2). Following 2.5 μM CCCP treatment the mitochondrial membrane potential of the cells was eliminated, as demonstrated by the increase of the monomer emission [20 (link)].
+ Open protocol
+ Expand
3

Cell Cycle Analysis by PI Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell cycle was analyzed by Propidium Iodide (PI) staining. Briefly, 1,000,000 cells were fixed with 2 ml cold ethanol for 1 hour at 4°C. After washed with ice-cold PBS for two times, the cells were suspended with 1 ml of PI staining solution (40 μg/ml in PBS), supplemented with 50 μl of RNase A stock solution (10 μg/ml) and incubated 2 hour at 4°C. Then cell cycle was analyzed using FACSScan flow cytometer (Becton Dickinson, San Jose, CA).
+ Open protocol
+ Expand
4

Phenotypic Characterization of AT-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
AT-MSCs (106) were trypsinized and incubated with fluorescein isothiocyanate (FITC)-conjugated CD34, CD45, CD90, phycoerythrin (PE) -conjugated human leukocyte antigen (HLA)-DR, CD11b, CD29, CD105 (mouse, monoclonal, 1:200; eBioscience, San Diego, CA, USA) or PE-conjugated CD3, CD73, CD117, (mouse, monoclonal, 1:200; BD Biosciences, San Jose, CA, USA) antibodies for 30 minutes at RT, followed by three washes. Staining with unconjugated anti-programmed death ligand (PDL) 1 (rabbit, polyclonal, 1:100; BD Biosciences), FITC-conjugated goat anti-rabbit immunoglobulin G (IgG) antibody (Ab) (goat, polyclonal, 1:200; BD Biosciences) was used as a secondary antibody. The fluorescent labeled cells were analyzed on a FACSscan flow cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA) using CELLQuest Pro software (Becton-Dickinson).
+ Open protocol
+ Expand
5

Cell Cycle Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
CT26 cells (1 × 106) were harvested and washed twice with cold phosphate-buffered saline (PBS). Cells then were stained with 500 µl of propidium iodide (PI) staining solution (50 mg/ml PI, 0.1% Triton X-100, 200 mg/ml DNase-free RNase in PBS) for 30 min at room temperature in the dark. Ten thousand events per sample were acquired using a FACS-scan flow cytometer (Becton-Dickinson, San Jose, CA, USA), and the percentage of cells in G0/G1, S, G2/M, and sub-G2/M phases of the cell cycle were determined using CELL Quest software (Becton-Dickinson).
+ Open protocol
+ Expand
6

Immunophenotypic Analysis of Peripheral Lymphocytes in COVID-19 Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood white blood cells (WBC) of all participants were isolated from their hemogram tubes with EDTA taken for their routine tests by using erythrocyte lysing solution (155 mM NH4Cl; 10 mM KHCO3; 0,1 mM EDTA; pH:7.3). The following fluorochrome labeled monoclonal antibodies (mAb) and isotype-matched controls were used for two–three color phenotypic analysis: anti-IgG1, anti-IgG2a, anti-CD45, anti-CD3; anti-CD4; anti-CD8; anti-CD16; anti-CD56; anti-CD19; anti-HLA-DR; anti-CD69, (Becton&Dickinson Corp, San Jose, CA, USA). Cells were acquired and analyzed using CellQuest software on a FACS scan flow cytometer (Becton Dickinson Inc, San Jose, CA, USA). Lymphocytes were gated according to their forward and side scatter characteristics and their specific CD markers. Markers were evaluated as percentages. In 13 of 20 patients, peripheral lymphocyte subset analysis was repeated 1 week later. A total of 10 KTR without COVID-19 was used as control group.
+ Open protocol
+ Expand
7

Cell Cycle Analysis of Fe3O4@Glu/BTSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of Fe3 O4@Glu/BTSC on G0/G1, S and G2/M phases was evaluated according to the method described by Davy and Doorbar.26 (link) After culture, the cells were treated with concentrations of 10–20 μL of Fe3 O4@Glu/BTSC and 0.05% DMSO (as negative control) for 15 hours. Rinsing was performed with PBS and kept in a -20°C freezer for 24 hours with the addition of 70% alcohol overnight. To perform flow cytometry, the cells were washed again with cold PBS and suspended for 15 minutes at room temperature by adding 50 µL of RNase A 100 μg/mL. In the next step, propidium iodide was added to the suspension to reach the final concentration of 20 μg/mL. The suspension was placed at room temperature for 20 minutes. Cell cycle phases were analyzed by FACS Scan Flow Cytometer (Becton-Dickinson CA, USA). Data were analyzed with three replications, and different phases of the cell cycle were analyzed using flowing software 2.5.1.
+ Open protocol
+ Expand
8

Apoptosis Assay of Drug-Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into 6-well plates and incubated for 48 hours with a drug-containing medium when the cell confluency reached 70%. Then, 1 × 106 cells were collected and stained according to the steps of the apoptosis kit instructions, and the percentage of apoptotic cells was determined using a FACSscan flow cytometer (Becton-Dickinson, NJ, USA).
+ Open protocol
+ Expand
9

Receptor Expression in Diabetic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the surface expression of receptors, CD34+ cells from diabetics and non-diabetics were treated with FcR blocking reagent (anti-CD16/32, TruStain, BioLegend) and then stained with Zenon Alexa Fluor 488-(Invitrogen) tagged primary mouse monoclonal anti-human VEGFR1, antihuman VEGFR2, and CXCR4 antibodies (R&D systems), or isotype control antibodies for 20 minutes on ice. Cells were analyzed by a FACS Scan flow cytometer (Becton Dickinson).
+ Open protocol
+ Expand
10

Par-4 Mutants Modulate TRAIL-Induced Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells transfected with Par-4 mutants were either treated with recombinant His-TRAIL (500 ng/ml) or Paclitaxel 200 nM (Calbiochem). Cells were harvested and fixed with 0.2% paraformaldehyde in presence of 1 mg/ml of DAPI or Hoetsch 33342 (Sigma-Aldrich) to stain the nuclei. Apoptosis was measured by counting cells that are condensed and fragmented. Images were acquired using the Cell Observer station (Zeiss, Göttingen, Germany). Briefly, the system consists of an inverted microscope AxioVert 200M (Zeiss) equipped for fluorescence with a CCD camera. All the system is motorized and controlled by the Axiovision software (Zeiss). Apoptosis was also assessed by the determination of PARP and caspase 8 cleavage by western blotting using anti-mouse caspase-8 from R&D and rabbit PARP (detection of the short cleaved form) or mouse PARP (detection of the large fragment) antibodies (Santa Cruz).
For FACS analysis, cells stained with APO and FITC–annexin V conjugate were analyzed by flow cytometry using a FACS Scan flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Caspase-3 activity was measured by FACS using the fluorochrome benzyloxycarbonyl-Asp-Glu-Val-Asp (OMe) fluoromethylketone (PromoKine Caspase-3 kit, PromoCell, Heidelberg, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!